Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Norwegian Cruise Line Holdings Ltd (NCLH) vs 22nd Century Group Inc (XXII) Price & Performance

Norwegian Cruise Line Holdings LtdTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Norwegian Cruise Line Holdings Ltd vs 22nd Century Group Inc — how do they compare? Norwegian Cruise Line Holdings Ltd trades at $15.58 (market cap $7.11B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Norwegian Cruise Line Holdings Ltd is far larger — about 11436.9× 22nd Century Group Inc's market cap, and Norwegian Cruise Line Holdings Ltd is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Norwegian Cruise Line Holdings Ltd for 68 Days and 22nd Century Group Inc for 32 Days on average.

NCLHXXII
Market Cap
$7.11B$621.67K
Volume
22,683,26845,625
Sector
Consumer CyclicalConsumer Staples
52-Week High
$25.02$483.00
52-Week Low
$14.12$0.80
Typical Hold Time
68 Days32 Days
Enterprise Value
$21.93B-$3.69M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Norwegian Cruise Line Holdings Ltd

NCLH trades at $15.57, up 3.46% today, with a bullish technical signal and strong recent earnings beats. The company reported Q2 2026 EPS of $0.48, beating expectations, and expects Q3 results to exceed guidance. Valuation metrics appear attractive with a P/E of 9.39 and P/S of 0.75. Revenue has grown from $4.8B in 2022 to $9.83B in 2025, though net income margin declined to 4.3% from 9.6% in 2024.

The outlook is mixed: analyst consensus is bullish with a $20.86 price target, but the company faces yield pressure and high debt levels. Investment opportunity lies in continued operational recovery and compelling valuation, while risks include Caribbean pricing pressure and significant leverage that could constrain financial flexibility.

22nd Century Group Inc

22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.

While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NCLH
9% Buy91% Sell
Avg holding period · 68 Days
XXII
100% Buy0% Sell
Avg holding period · 32 Days

Top news

Latest headlines on both assets

About Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.

Read more on NCLH →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →